Brazil's Non-Small-Cell Lung Cancer Drug Market will Reach $240 Million by 2014

Tuesday, July 6, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

Eli Lilly and Roche Dominated the Non-Small-Cell Lung Cancer Drug Market in Brazil in 2009, According to a New Report from Decision Resources

For more information, contact:

Christopher Comfort

Decision Resources

781-296-2597

ccomfort@dresources.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook